View in EDS HTML Full Text PDF Full Text

Pilot study evaluating everolimus molecular mechanisms in tuberous sclerosis complex and focal cortical dysplasia.

Saved in:
Bibliographic Details
Title: Pilot study evaluating everolimus molecular mechanisms in tuberous sclerosis complex and focal cortical dysplasia.
Authors: Leitner DF; Comprehensive Epilepsy Center, New York University School of Medicine, New York, New York, United States of America., Kanshin E; Proteomics Laboratory, Division of Advanced Research Technologies, NYU School of Medicine, New York, New York, United States of America., Askenazi M; Biomedical Hosting LLC, Arlington, Massachusetts, United States of America.; Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, New York, United States of America., Siu Y; Metabolomics Core Resource Laboratory, New York University School of Medicine, New York, New York, United States of America., Friedman D; Comprehensive Epilepsy Center, New York University School of Medicine, New York, New York, United States of America., Devore S; Comprehensive Epilepsy Center, New York University School of Medicine, New York, New York, United States of America., Jones D; Metabolomics Core Resource Laboratory, New York University School of Medicine, New York, New York, United States of America., Ueberheide B; Proteomics Laboratory, Division of Advanced Research Technologies, NYU School of Medicine, New York, New York, United States of America.; Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, New York, United States of America.; Center for Cognitive Neurology, Department of Neurology, New York University School of Medicine, New York, New York, United States of America., Wisniewski T; Center for Cognitive Neurology, Department of Neurology, New York University School of Medicine, New York, New York, United States of America.; Department of Psychiatry, New York University School of Medicine, New York, New York, United States of America.; Department of Pathology, New York University School of Medicine, New York, New York, United States of America., Devinsky O; Comprehensive Epilepsy Center, New York University School of Medicine, New York, New York, United States of America.
Source: PloS one [PLoS One] 2022 May 19; Vol. 17 (5), pp. e0268597. Date of Electronic Publication: 2022 May 19 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35587487
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pilot study evaluating everolimus molecular mechanisms in tuberous sclerosis complex and focal cortical dysplasia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Leitner+DF%22">Leitner DF</searchLink>; Comprehensive Epilepsy Center, New York University School of Medicine, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Kanshin+E%22">Kanshin E</searchLink>; Proteomics Laboratory, Division of Advanced Research Technologies, NYU School of Medicine, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Askenazi+M%22">Askenazi M</searchLink>; Biomedical Hosting LLC, Arlington, Massachusetts, United States of America.; Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Siu+Y%22">Siu Y</searchLink>; Metabolomics Core Resource Laboratory, New York University School of Medicine, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Friedman+D%22">Friedman D</searchLink>; Comprehensive Epilepsy Center, New York University School of Medicine, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Devore+S%22">Devore S</searchLink>; Comprehensive Epilepsy Center, New York University School of Medicine, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Jones+D%22">Jones D</searchLink>; Metabolomics Core Resource Laboratory, New York University School of Medicine, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Ueberheide+B%22">Ueberheide B</searchLink>; Proteomics Laboratory, Division of Advanced Research Technologies, NYU School of Medicine, New York, New York, United States of America.; Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, New York, United States of America.; Center for Cognitive Neurology, Department of Neurology, New York University School of Medicine, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Wisniewski+T%22">Wisniewski T</searchLink>; Center for Cognitive Neurology, Department of Neurology, New York University School of Medicine, New York, New York, United States of America.; Department of Psychiatry, New York University School of Medicine, New York, New York, United States of America.; Department of Pathology, New York University School of Medicine, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Devinsky+O%22">Devinsky O</searchLink>; Comprehensive Epilepsy Center, New York University School of Medicine, New York, New York, United States of America.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2022 May 19; Vol. 17 (5), pp. e0268597. <i>Date of Electronic Publication: </i>2022 May 19 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35587487
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.pone.0268597
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e0268597
    Titles:
      – TitleFull: Pilot study evaluating everolimus molecular mechanisms in tuberous sclerosis complex and focal cortical dysplasia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Leitner DF
      – PersonEntity:
          Name:
            NameFull: Kanshin E
      – PersonEntity:
          Name:
            NameFull: Askenazi M
      – PersonEntity:
          Name:
            NameFull: Siu Y
      – PersonEntity:
          Name:
            NameFull: Friedman D
      – PersonEntity:
          Name:
            NameFull: Devore S
      – PersonEntity:
          Name:
            NameFull: Jones D
      – PersonEntity:
          Name:
            NameFull: Ueberheide B
      – PersonEntity:
          Name:
            NameFull: Wisniewski T
      – PersonEntity:
          Name:
            NameFull: Devinsky O
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 05
              Text: 2022 May 19
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1932-6203
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: PloS one
              Type: main
ResultId 1